Assistive AI in Lung Cancer Screening: A Retrospective Multinational Study in the United States and Japan
View abstract on PubMed
Summary
This summary is machine-generated.An artificial intelligence (AI) assistant improved lung cancer screening specificity in multinational studies. This AI tool enhanced radiologists' ability to identify actionable findings, warranting further international investigation.
Area Of Science
- Radiology
- Artificial Intelligence
- Oncology
Background
- Lung cancer screening is crucial for early detection.
- Multinational studies are needed to validate AI tools in diverse clinical settings.
Purpose Of The Study
- To evaluate the impact of an AI assistant on lung cancer screening workflows.
- To assess AI's effect on radiologists' performance in U.S. and Japan-based studies.
Main Methods
- Two retrospective randomized multireader multicase studies involving 627 low-dose chest CT cases.
- 62 radiologists interpreted cases with and without AI assistance, totaling 7524 interpretations.
- Evaluation metrics included AUC, sensitivity, and specificity for recall recommendations.
Main Results
- AI assistance increased radiologists' AUC by 0.023 in both U.S. and Japan studies.
- Specificity for actionable findings improved by 5.5% (U.S.) and 6.7% (Japan) with AI.
- No significant difference in sensitivity was observed with AI assistance.
Conclusions
- The AI interface enhanced lung cancer screening specificity in U.S. and Japan-based reader studies.
- Further evaluation in diverse international screening environments is recommended.
- AI shows promise in improving the accuracy of lung cancer detection.

